Goldshield and affiliates rebrand as Mercury Pharma

Goldshield, an international speciality pharmaceutical company selling niche generic  prescription and non-prescription medicines, and its Antigen, Anpharm and Forley affiliates, came together yesterday under a single unifying name and identity: Mercury Pharma.

Goldshield was acquired by HgCapital, formerly known as Mercury Private Equity, in a management buyout valued at around $200 million in 2009.

This rebrand, the company says, is its public declaration of the new era that the group has commenced, with new owners, a new senior management and a revised strategy as an international specialty pharmaceuticals business. This development builds on the success of the past 20 years and signals our ambitions to take the group to new heights, it states.
A new logo has been adopted and a new packaging livery will be phased in over the coming months.